Weill Cornell awarded $11.3 million SPORE grant for prostate cancer

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Weill Cornell Medicine was awarded a five-year, $11.3 million Specialized Programs of Research Excellence grant from NCI to improve the detection, diagnosis and treatment of prostate cancer.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe

YOU MAY BE INTERESTED IN

Login